Paper445463
Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide.
Huberman E and 2 others. Cancer Res, 1979. Cited by 211 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Stimulation of differentiated functions in human melanoma cells by tumor-promoting agents and dimethyl sulfoxide. Papers, record 445463. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/445463
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Differentiation | Major topic |
| Dimethyl Sulfoxide | Major topic |
| Melanoma | Major topic |
| Phorbols | Major topic |
| Tetradecanoylphorbol Acetate | Major topic |
| Cell Division | |
| Cells, Cultured | |
| Dose-Response Relationship, Drug | |
| Gangliosides | |
| Humans | |
| Melanins | |
| Phorbol Esters |
Source PubMed
Cited by37
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 211 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41,776,748 | QUILPEN Provides Independent and Label-Free Single-Cell Quantification of Pigmentation Dynamics and Organelle Content. | Pigment Cell Melanoma Res | 2026 | https://conductscience.org/library/papers/41776748 | PubMed |
| 41,033,672 | Dimethyl Sulfoxide Suppresses Fusarium graminearum Pathogenicity by Modulating Key Life Cycle Traits. | Plant Pathol J | 2025 | https://conductscience.org/library/papers/41033672 | PubMed |
| 36,906,655 | UHRF1/UBE2L6/UBR4-mediated ubiquitination regulates EZH2 abundance and thereby melanocytic differentiation phenotypes in melanoma. | Oncogene | 2023 | https://conductscience.org/library/papers/36906655 | PubMed |
| 24,744,794 | Dimethyl Sulfoxide Suppresses Mouse 4T1 Breast Cancer Growth by Modulating Tumor-Associated Macrophage Differentiation. | J Breast Cancer | 2014 | https://conductscience.org/library/papers/24744794 | PubMed |
| 24,143,183 | Identification of genes potentially regulated by human polynucleotide phosphorylase (hPNPase old-35) using melanoma as a model. | PLoS One | 2013 | https://conductscience.org/library/papers/24143183 | PubMed |
| 22,654,640 | Evaluation of melanogenesis in A-375 cells in the presence of DMSO and analysis of pyrolytic profile of isolated melanin. | ScientificWorldJournal | 2012 | https://conductscience.org/library/papers/22654640 | PubMed |
| 8,097,141 | Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro. | Clin Exp Metastasis | 1993 | https://conductscience.org/library/papers/8097141 | PubMed |
| 7,937,935 | Inducing differentiation of transformed cells with hybrid polar compounds: a cell cycle-dependent process. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/7937935 | PubMed |
| 7,426,299 | A human melanoma cell line established from xenograft in athymic mice. | Br J Cancer | 1980 | https://conductscience.org/library/papers/7426299 | PubMed |
| 7,001,476 | Selective effects of phorbol 12-myristate 13-acetate on myofibrils and 10-nm filaments. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/7001476 | PubMed |
| 6,952,249 | Selective proliferation of normal human melanocytes in vitro in the presence of phorbol ester and cholera toxin. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6952249 | PubMed |
| 6,940,123 | Alterations in polyamine levels induced by phorbol diesters and other agents that promote differentiation in human promyelocytic leukemia cells. | Proc Natl Acad Sci U S A | 1981 | https://conductscience.org/library/papers/6940123 | PubMed |
| 6,934,372 | The effect of tumor-promoting phorbol diesters on terminal differentiation of cells in culture. | Mol Cell Biochem | 1980 | https://conductscience.org/library/papers/6934372 | PubMed |
| 6,929,508 | Control of differentiation of a mammary cell line by lipids. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6929508 | PubMed |
| 6,774,342 | Studies on the mechanism of skin tumor promotion: evidence for several stages in promotion. | Proc Natl Acad Sci U S A | 1980 | https://conductscience.org/library/papers/6774342 | PubMed |
| 6,621,538 | Tumor-promoting phorbol esters inhibit procollagen synthesis at a pretranslational level in JB-6 mouse epidermal cells. | Mol Cell Biol | 1983 | https://conductscience.org/library/papers/6621538 | PubMed |
| 6,480,823 | Tumor promoters stimulate hyperplasia of microtubule organizing center and inhibit DNA synthesis in cultured cells. | J Clin Invest | 1984 | https://conductscience.org/library/papers/6480823 | PubMed |
| 6,411,733 | Regulation of tyrosinase in human melanocytes grown in culture. | J Cell Biol | 1983 | https://conductscience.org/library/papers/6411733 | PubMed |
| 6,317,508 | Factors affecting the CEA secretion of human adenocarcinoma cell lines into the spent medium. | Gastroenterol Jpn | 1983 | https://conductscience.org/library/papers/6317508 | PubMed |
| 6,300,862 | Tumor promoter 12-O-tetradecanoylphorbol 13-acetate, like epidermal growth factor, stimulates cell proliferation and inhibits differentiation of mouse mammary epithelial cells in culture. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6300862 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/445463
GET https://conductscience.org/api/papers/v1/445463/cited_by?page=2